Zarasyl Brings Regenerative Technology to the market for Companion Animal Skin and Woundcare

January 11th, 2023 Athboy, Ireland - Following the success of the equine product, Zarasyl has released a much anticipated new Companion Animal Solution for skin and wound care. The veterinarian-backed regenerative formula is powered by an exclusive patented technology composed of amorphous silica and inspired by over 10 years of research and innovation. 

Zarasyl Companion Animal Solution for wounds & abrasions is formulated with technology that works. Zarasyl’s unique regenerative formula contains amorphous silica with a molecular structure tailored to provide sustained delivery of orthosilicic acid to the skin. Orthosilicic acid is the bioavailable form of silicon associated with healthy connective tissue growth. Zarasyl’s Companion Animal Solution has been formulated to address all the requirements for an ideal wound healing modality. Developed in conjunction with a team of scientists, Zarasyl Solution for Wounds & Abrasions is bringing human science and regenerative technology to the companion animal industry.

Zarasyl Companion Animal Solution can be used on wounds, abrasions, and a variety of dermatologic issues. Veterinarians and owners alike can take advantage of the regenerative technology in Zarasyl Companion Animal Solution for the management of: 

• Secondary Wound Intention,
• Surgical incisions,
• Pyotraumatic dermatitis,
• Hypersensitivity/allergic reactions,
• Miliary dermatitis,
• Fungal infection,
• Bacterial folliculitis,
• Trauma,
• Abrasions and more..

Referring to Zarasyl in a use case, Jon Todd, DVM, owner Logan County Animal Clinic, Russellville, KY stated “We had a case presented with a 10cm mass which we removed through an elliptical incision. Because of the size and infection involved, we chose to allow the area to heal by second intention. We packed the void using Zarasyl Companion until the time it could be closed surgically. The wound closed entirely within 3 weeks with minimal scarring. I have treated similar surgical wounds and feel that Zarasyl Companion greatly increased the rate of healing and decreased scarring.”  

As a company that is passionate about science and animal welfare, Zarasyl is delighted to expand the benefits of this amorphous silica formula to the companion animal market. Zarasyl CEO Adrienne Magnier states, “Since 2019, we’ve worked with veterinarians to improve animal welfare. After seeing how our patented formula successfully improved the lives of equines across the globe, we knew we had to reach more animals in need. In 2022, we were able to see the fruition of those efforts. We’re delighted to bring our regenerative technology to the companion animal market.”

####

Established in 2019, Zarasyl is an innovative animal skincare company that has brought cutting-edge human science to veterinarians and equestrians worldwide. The silicate technology behind our steroid and antibiotic-free products was initially developed for use in human science, but founders Adrienne Magnier quickly realized the benefits for animal health as well. Created in collaboration with a team of scientists, Zarasyl is a competition-safe topical cream containing an amorphous silica with a molecular structure tailored to provide sustained delivery of orthosilicic acid to the skin. Zarasyl Companion Animal Solution for Wounds & Abrasions is available through our network of distribution partners.

To discover more about Zarasyl and the science behind it, visit zarasyl.com.

For all media related queries, please contact Valerie Kennedy at valerie.kennedy@zarasyl.com.